Filter posts

Biotech CEOs Talk JOBS Act and IPO Experiences at 2014 BIO Investor Forum

The JOBS Act has contributed to a dramatic acceleration in new biotech IPOs since its …

BIO Investor Forum Company Snapshot: Syntrix Biosystems

1.     What is your company’s lead product or technology? Omnitram (O-desmethyltramadol) is a novel  oral …

BIO Urges Comprehensive Tax Reform

Earlier this week, the Treasury Department issued a notice of its intent to propose rules …

Members of Congress Agree: Reg A+ Rules Need National Standard

We’ve written before about the importance of implementing Title IV of the JOBS Act (commonly …

NCATS SBIR Announces Funding For Biotechs and Small Business Technology Development

The NIH National Center for Advancing Translational Sciences (NCATS) is seeking qualified applicants for its …

Investment in NJ Biotech is Way Up

Total funding of New Jersey life sciences companies spiked in 2013 with approximately $900 million …

FierceBiotech Names 2014 Fierce 15

FierceBiotech released their much-anticipated 2014 Fierce 15 list today, their annual list of private biotech …

Virtual Resources: BIO BizLink Meets the C&EN Online Trade Show

For those who may not have heard, BIO recently launched a new initiative: BIO BizLink. …

CFO Magazine: On the IPO On-Ramp

CFO Magazine highlighted the impact of the Jumpstart Our Business Startups (JOBS) Act on smaller …

The Eyes Have It According to Recent VC Funding Patterns

A recent Wall Street Journal analysis of venture capital investment trends since 1999 reveals which …